Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00256750
Status:
COMPLETED
Last Update Posted:
2016-08-19
First Post:
2005-11-15
Brief Title:
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression BENEFIT
Sponsor:
Organization:
Bristol-Myers Squibb